© 2025 swii.ch health

Rare Insights

Exploring the ideas, innovations, and individuals shaping the future of rare disease.

Patient Engagement in the 110-Day EU Joint Clinical Assessment (JCA) Sprint

July 15, 2025 | 1:41 pm

From 12 January 2028, every EU orphan-designated therapy must navigate a 110-day Joint Clinical Assessment (JCA) timeline[…]

Read more

RAREready™ – AI-powered EU JCA & HTA readiness

© 2025 swii.ch health.

Privacy Policy
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept